Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
148.84M | 171.40M | 161.05M | 148.91M | 142.47M | Gross Profit |
93.28M | 110.27M | 104.28M | 97.92M | 91.42M | EBIT |
15.61M | 28.97M | 25.36M | 35.54M | 28.31M | EBITDA |
32.77M | 33.23M | 40.47M | 51.52M | 45.13M | Net Income Common Stockholders |
14.92M | 20.74M | 20.12M | 27.14M | 15.85M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
62.11M | 78.99M | 103.38M | 113.64M | 80.28M | Total Assets |
165.59M | 177.36M | 177.93M | 181.66M | 145.34M | Total Debt |
10.64M | 12.74M | 13.46M | 13.99M | 10.63M | Net Debt |
-34.37M | -50.38M | -50.28M | -96.39M | -66.41M | Total Liabilities |
23.72M | 32.44M | 32.47M | 29.44M | 20.26M | Stockholders Equity |
141.87M | 144.92M | 145.46M | 152.22M | 125.08M |
Cash Flow | Free Cash Flow | |||
15.63M | 38.80M | 26.76M | 44.61M | 23.68M | Operating Cash Flow |
18.76M | 40.66M | 37.91M | 46.81M | 30.09M | Investing Cash Flow |
-8.02M | -12.57M | -47.11M | -2.13M | -32.10M | Financing Cash Flow |
-28.55M | -31.98M | -37.43M | -11.33M | -19.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$138.88M | 13.89 | 7.02% | 9.60% | -17.13% | -51.35% | |
66 Neutral | HK$9.15B | 14.45 | 9.30% | ― | 7.28% | -13.77% | |
61 Neutral | $6.97B | 11.38 | 2.88% | 3.90% | 2.64% | -22.07% | |
53 Neutral | HK$238.31M | 2.31 | 16.80% | 47.41% | -41.24% | -36.17% | |
48 Neutral | HK$1.72B | 86.41 | 0.59% | ― | -21.05% | -87.68% | |
46 Neutral | HK$100.22M | ― | -21.15% | ― | 61.36% | 8.48% |